Potassium Perchlorate

CHEMBL1200696 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
138.6 g/mol
LogP
Phase
4

Potassium perchlorate is an inorganic salt that acts as a competitive inhibitor of the sodium-iodide symporter (NIS), blocking iodide uptake into the thyroid gland and thereby reducing thyroid hormone synthesis. It is used for the treatment of hyperthyroidism and thyrotoxicosis, and has been used to prevent iodide-induced hyperthyroidism during iodinated contrast administration.

Moleküler Ağırlık

138,5500 g/mol

TPSA

74,30 Ų

Terapötik Alanlar

Etki Mekanizması

Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mekanizma

Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

[K+].[O-][Cl+3]([O-])([O-])[O-]

InChI

InChI=1S/ClHO4.K/c2-1(3,4)5;/h(H,2,3,4,5);/q;+1/p-1

Molecular Formula

ClKO4

HBD / HBA

- / 4

Döndürülebilir Bağlar

0

Ağır Atomlar

6

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

Potassium perchlorate is an inorganic salt that acts as a competitive inhibitor of the sodium-iodide symporter (NIS), blocking iodide uptake into the thyroid gland and thereby reducing thyroid hormone synthesis. It is used for the treatment of hyperthyroidism and thyrotoxicosis, and has been used to prevent iodide-induced hyperthyroidism during iodinated contrast administration.

Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.

Yes, Potassium Perchlorate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200696. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 516900. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.